Stock Comparison
ASND vs REGN
Ascendis Pharma AS and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$17.10B
$66.35B
P/E (TTM)
30.3
15.5
Forward P/E
16.2
14.1
Price/Sales
19.8
4.5
Price/Book
30.9
2.1
EV/EBITDA
-20.8
10.5
Dividend Yield
—
0.58%
Profitability
Net Margin
57.30%
29.60%
Operating Margin
10.10%
20.70%
Return on Equity
33.30%
14.50%
Return on Assets
-0.60%
6.13%
Growth (YoY)
Revenue Growth
144.30%
19.00%
Earnings Growth
0.00%
-7.20%
Price & Risk
Beta
0.5
0.2
52-Week High
$271.89
$818.90
52-Week Low
$160.86
$516.07
Analyst Target
$291.15
$833.31
Compare ASND and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.